大颗粒淋巴细胞白血病

夏宁余, 程范军. 大颗粒淋巴细胞白血病[J]. 临床血液学杂志, 2021, 34(9): 674-679. doi: 10.13201/j.issn.1004-2806.2021.09.016
引用本文: 夏宁余, 程范军. 大颗粒淋巴细胞白血病[J]. 临床血液学杂志, 2021, 34(9): 674-679. doi: 10.13201/j.issn.1004-2806.2021.09.016
XIA Ningyu, CHENG Fanjun. Large granular lymphocyte leukemia[J]. J Clin Hematol, 2021, 34(9): 674-679. doi: 10.13201/j.issn.1004-2806.2021.09.016
Citation: XIA Ningyu, CHENG Fanjun. Large granular lymphocyte leukemia[J]. J Clin Hematol, 2021, 34(9): 674-679. doi: 10.13201/j.issn.1004-2806.2021.09.016

大颗粒淋巴细胞白血病

详细信息
    通讯作者: 程范军,E-mail:chengfanjun001@sina.com
  • 中图分类号: R733.7

Large granular lymphocyte leukemia

More Information
  • 加载中
  • [1]

    Lamy T,Moignet A,Loughran TP Jr.LGL leukemia:from pathogenesis to treatment[J].Blood,2017,129(9):1082-1094.

    [2]

    Swerdlow SH,Campo E,Pileri SA,et al.The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J].Blood,2016,127(20):2375-2390.

    [3]

    Jerez A,Clemente MJ,Makishima H,et al.STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia[J].Blood,2012,120(15):3048-3057.

    [4]

    Rajala HL,Eldfors S,Kuusanmäki H,et al.Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia[J].Blood,2013,121(22):4541-4550.

    [5]

    Dinmohamed AG,Brink M,Visser O,et al.Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013[J].Leukemia,2016,30(6):1449-1451.

    [6]

    Shah MV,Hook CC,Call TG,et al.A population-based study of large granular lymphocyte leukemia[J].Blood Cancer J,2016,6(8):e455.

    [7]

    Kimura H,Ito Y,Kawabe S,et al.EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts:prospective analysis of 108 cases[J].Blood,2012,119(3):673-686.

    [8]

    Bareau B,Rey J,Hamidou M,et al.Analysis of a French cohort of patients with large granular lymphocyte leukemia:a report on 229 cases[J].Haematologica,2010,95(9):1534-1541.

    [9]

    Zhu Y,Gao Q,Hu J,et al.Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia:A single-institution experience[J].Leuk Res,2020,90:106299.

    [10]

    Moignet A,Lamy T.Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia[J].Am Soc Clin Oncol Educ Book,2018,38:616-625.

    [11]

    Cheon H,Dziewulska KH,Moosic KB,et al.Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia[J].Curr Hematol Malig Rep,2020,15(2):103-112.

    [12]

    杨瑞,陈灿,李沂玮,等.32例T大颗粒淋巴细胞白血病的临床特征分析[J].临床血液学杂志,2020,33(7):508-513.

    [13]

    Huang L,Liu D,Wang N,et al.Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia[J].Cell Res,2018,28(2):172-186.

    [14]

    Fasan A,Kern W,Grossmann V,et al.STAT3 mutations are highly specific for large granular lymphocytic leukemia[J].Leukemia,2013,27(7):1598-1600.

    [15]

    Andersson E,Kuusanmäki H,Bortoluzzi S,et al.Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia[J].Leukemia,2016,30(5):1204-1208.

    [16]

    Rajala HL,Olson T,Clemente MJ,et al.The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia[J].Haematologica,2015,100(1):91-99.

    [17]

    Barilà G,Teramo A,Calabretto G,et al.Stat3 mutations impact on overall survival in large granular lymphocyte leukemia:a single-center experience of 205 patients[J].Leukemia,2020,34(4):1116-1124.

    [18]

    Teramo A,Barilà G,Calabretto G,et al.STAT3 mutation impacts biological and clinical features of T-LGL leukemia[J].Oncotarget,2017,8(37):61876-61889.

    [19]

    Andersson EI,Tanahashi T,Sekiguchi N,et al.High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia[J].Blood,2016,128(20):2465-2468.

    [20]

    Klein K,Witalisz-Siepracka A,Maurer B,et al.STAT5B(N642H)drives transformation of NKT cells:a novel mouse model for CD56(+)T-LGL leukemia[J].Leukemia,2019,33(9):2336-2340.

    [21]

    Savola P,Brück O,Olson T,et al.Somatic STAT3 mutations in Felty syndrome:an implication for a common pathogenesis with large granular lymphocyte leukemia[J].Haematologica,2018,103(2):304-312.

    [22]

    Clemente MJ,Wlodarski MW,Makishima H,et al.Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia[J].Blood,2011,118(16):4384-4393.

    [23]

    Sandberg Y,Kallemeijn MJ,Dik WA,et al.Lack of common TCRA and TCRB clonotypes in CD8(+)/TCRαβ(+)T-cell large granular lymphocyte leukemia:a review on the role of antigenic selection in the immunopathogenesis of CD8(+)T-LGL[J].Blood Cancer J,2014,4(1):e172.

    [24]

    Steinway SN,Leblanc F,Loughran TP Jr.The pathogenesis and treatment of large granular lymphocyte leukemia[J].Blood Rev,2014,28(3):87-94.

    [25]

    Yu J,Mitsui T,Wei M,et al.NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human[J].J Clin Invest,2011,121(4):1456-1470.

    [26]

    Mishra A,Liu S,Sams GH,et al.Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation[J].Cancer Cell,2012,22(5):645-655.

    [27]

    Mishra A,Sullivan L,Caligiuri MA.Molecular pathways:interleukin-15 signaling in health and in cancer[J].Clin Cancer Res,2014,20(8):2044-2050.

    [28]

    Teramo A,Gattazzo C,Passeri F,et al.Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia[J].Blood,2013,121(19):3843-3854,s1.

    [29]

    Yang J,Leblanc FR,Dighe SA,et al.TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia[J].Blood,2018,131(25):2803-2815.

    [30]

    Johansson P,Bergmann A,Rahmann S,et al.Recurrent alterations of TNFAIP3(A20) in T-cell large granular lymphocytic leukemia[J].Int J Cancer,2016,138(1):121-124.

    [31]

    Liu X,Ryland L,Yang J,et al.Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia[J].Blood,2010,116(20):4192-4201.

    [32]

    Leblanc FR,Liu X,Hengst J,et al.Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia[J].Cancer Biol Ther,2015,16(12):1830-1840.

    [33]

    Marchand T,Lamy T,Finel H,et al.Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia:a retrospective study of the European Society for Blood and Marrow Transplantation[J].Leukemia,2016,30(5):1201-1204.

    [34]

    Liao A,Broeg K,Fox T,et al.Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia[J].Blood,2011,118(10):2793-2800.

  • 加载中
计量
  • 文章访问数:  208
  • PDF下载数:  692
  • 施引文献:  0
出版历程
收稿日期:  2021-04-28

目录